Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 13:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- PLN 20.32T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | PLN 19.4B | PLN 55.27 | 0.94% down | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | PLN 38.7B | PLN 407.57 | 8.15% up | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | PLN 26.1B | PLN 384.59 | 0.60% down | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | PLN 21.2B | PLN 501.57 | 0.62% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | PLN 16B | PLN 116.98 | 0.88% down | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | PLN 30B | PLN 381.82 | 0.06% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | PLN 40.1B | PLN 265.61 | 5.44% up | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | PLN 19B | PLN 337.35 | 3.45% down | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | PLN 93.4B | PLN 81.47 | 0.83% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | PLN 112.7B | PLN 155.58 | 0.05% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | PLN 30.6B | PLN 87.89 | 3.60% up | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | PLN 34.3B | PLN 1,225.96 | 0.04% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | PLN 18.2B | PLN 166.19 | 1.59% down | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | PLN 158.6B | PLN 275.85 | 0.01% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | PLN 197.9B | PLN 169.64 | 0.92% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | PLN 126.2B | PLN 204.75 | 1.91% down | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | PLN 31.6B | PLN 188.20 | 3.08% up | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | PLN 273B | PLN 85.44 | 1.71% down | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | PLN 33.3B | PLN 510.81 | 2.00% up | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | PLN 24B | PLN 1,199.93 | 1.67% up | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | PLN 1.36T | PLN 553.47 | 3.90% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | PLN 19.4B | PLN 201.82 | 1.68% down | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | PLN 25.5B | PLN 627.58 | 0.94% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | PLN 63.9B | PLN 995.30 | 2.93% up | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | PLN 2.64T | PLN 1,095.45 | 2.15% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | PLN 24.3B | PLN 371.54 | 0.59% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | PLN 4.95T | PLN 5,554.58 | 2.32% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | PLN 489.1B | PLN 239.26 | 2.92% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | PLN 71.2B | PLN 1,085.93 | 0.32% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | PLN 392.9B | PLN 3,798.24 | 1.28% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | PLN 546.4B | PLN 2,154.95 | 0.42% up | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | PLN 53.6B | PLN 107.26 | 3.29% up | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | PLN 1.18T | PLN 623.49 | 2.46% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | PLN 2.03T | PLN 1,148.92 | 2.33% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | PLN 98.8B | PLN 2,319.20 | 1.16% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | PLN 61B | PLN 313.37 | 1.58% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | PLN 33.2B | PLN 478.19 | 2.08% up | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | PLN 47.8B | PLN 246.77 | 4.99% up | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | PLN 185.2B | PLN 1,621.28 | 2.34% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | PLN 642.5B | PLN 112.72 | 1.44% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | PLN 24.5B | PLN 173.18 | 0.28% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | PLN 50.2B | PLN 60.18 | 1.28% up | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | PLN 391.2B | PLN 195.15 | 1.34% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | PLN 1.11T | PLN 718.09 | 1.93% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | PLN 23.2B | PLN 34.02 | 1.85% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | PLN 454.5B | PLN 189.28 | 0.86% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | PLN 28.3B | PLN 538.28 | 1.43% down | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | PLN 29.8B | PLN 272.32 | 3.25% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | PLN 726.9B | PLN 419.70 | 0.22% down | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | PLN 698.1B | PLN 158.39 | 3.12% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | PLN 28.7B | PLN 206.16 | 0.64% down | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | PLN 19.4B | PLN 111.71 | 0.14% down | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | PLN 20.2B | PLN 241.95 | 0.22% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | PLN 139.7B | PLN 343.74 | 2.50% up | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | PLN 37.1B | PLN 1,599.11 | 5.67% down | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | PLN 29.5B | PLN 336.75 | 2.11% up | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | PLN 33.7B | PLN 42.18 | 1.59% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | PLN 105.6B | PLN 481.24 | 1.69% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | PLN 12.7B | PLN 65.28 | 0.87% up | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | PLN 18.3B | PLN 110.03 | 1.59% up | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | PLN 80.4B | PLN 600.15 | 4.54% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0171 PLN).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 13:33 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of PLN 20.32T as of 19 Nov 2026, 13:33 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.